NCT00336713View on ClinicalTrials.gov

A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

PHASE3CompletedINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Depressive Disorder
Interventions
DRUG

Saredutant (SR48968C)

oral administration (capsules)

DRUG

Placebo

oral administration (capsules)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY